Kuraray (3405) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
10 Feb, 2026Executive summary
Operating and net income declined in FY2025 due to lower sales volumes, negative inventory valuation, and impairment losses in the Isoprene and elastomer segments.
The company advanced its medium-term management plan, focusing on production optimization, business portfolio restructuring, sustainability, innovation, and organizational transformation.
Financial highlights
FY2025 net sales were ¥808.4 billion, down 2.2% year-over-year; operating income was ¥58.9 billion, down 30.8%; net income attributable to owners was ¥7.5 billion, a 76.5% decrease.
Ordinary income fell to ¥51.5 billion from ¥81.5 billion in FY2024.
Free cash flow dropped to ¥0.5 billion from ¥62.3 billion in FY2024.
Gross profit fell to ¥246,508 million from ¥267,520 million year-over-year.
Equity ratio decreased to 57.0% at year-end 2025.
Outlook and guidance
FY2026 forecasts: net sales ¥850.0 billion (+5.1%), operating income ¥70.0 billion (+18.9%), net income ¥40.0 billion (+435.6%).
ROE and ROIC are expected to improve to 5% and 6%, respectively, in FY2026.
CAPEX (decision basis) is set at ¥75.0 billion, down from ¥101.0 billion in FY2025.
Annual dividend for 2026 is planned at ¥64 per share, including a ¥10 commemorative dividend.
Latest events from Kuraray
- SentryGlas® dominates structural glass with high performance and sustainability, driving global growth.3405
Investor Update19 Dec 2025 - Profits fell over 50% year-over-year; forecasts cut and major share buyback completed.3405
Q3 202612 Nov 2025 - Profits and sales fell in 1H FY2025, but portfolio restructuring and buybacks advanced.3405
Q2 20268 Aug 2025 - High-performance PVOH products and cell culture solutions drive robust global growth outlook.3405
Investor Day 202519 Jun 2025 - Profits and shareholder returns rose, with robust guidance despite lower sales forecast.3405
Q3 202513 Jun 2025 - Record interim results and upgraded outlook, with increased dividends and share buybacks.3405
Q2 202513 Jun 2025 - Sales up, profits down; full-year outlook steady, major share buyback planned.3405
Q1 20266 Jun 2025 - Record sales and operating income, but net income fell on extraordinary losses; profit recovery forecast.3405
Q4 20255 Jun 2025